Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Philips NV
  6. News
  7. Summary
    PHIA   NL0000009538

PHILIPS NV

(PHIA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Periodic update on transaction details related to Philips' share repurchases

11/12/2021 | 05:07am EST
Nov 12, 2021
Periodic update on transaction details related to Philips' share repurchases
Amsterdam, the Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA) today reported that in the period from November 5, 2021 up to and including November 11, 2021 a total of 1,053,000 of its own common shares were repurchased, with a weighted average purchase price of EUR 41.40. These repurchases were made under the repurchase program for capital reduction purposes, which was announced on July 26, 2021. Since the start of the program, Philips also entered into a number of forward transactions, with settlement dates in 2022, 2023 and 2024. Further details can be found via this link.
About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Click here to read moreClick here to read less

Disclaimer

Royal Philips NV published this content on 12 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 November 2021 10:06:08 UTC.


ę Publicnow 2021
All news about PHILIPS NV
01/26Philips Ventilator Recall Gets US FDA's Most Serious Classification
MT
01/26U.S. FDA labels Philips expanded ventilator recall as most serious
RE
01/26U.S. FDA classifies Philips ventilator recall as most serious
RE
01/26Credit Suisse Cuts Price Target on Philips to EUR32.50 From EUR42, Maintains Neutral Ra..
MT
01/26PHILIPS NV : Jefferies remains Neutral
MD
01/26Royal Philips Launches At-Home Electrocardiogram Technology
MT
01/26Philips introduces first at-home, 12-lead ECG integrated solution for decentralized cli..
AQ
01/26Philips Introduces First At-Home, 12-Lead ECG Integrated Solution for Decentralized Cli..
CI
01/25PHILIPS NV : Buy rating from UBS
MD
01/25Philips Fourth Quarter and Annual Results 2021
AQ
More news
Analyst Recommendations on PHILIPS NV
More recommendations
Financials
Sales 2021 17 287 M 19 278 M 19 278 M
Net income 2021 3 406 M 3 798 M 3 798 M
Net Debt 2021 4 321 M 4 818 M 4 818 M
P/E ratio 2021 7,40x
Yield 2021 3,03%
Capitalization 25 224 M 28 130 M 28 130 M
EV / Sales 2021 1,71x
EV / Sales 2022 1,64x
Nbr of Employees 78 189
Free-Float 98,2%
Chart PHILIPS NV
Duration : Period :
Philips NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHILIPS NV
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 29,01 €
Average target price 38,16 €
Spread / Average Target 31,5%
EPS Revisions
Managers and Directors
Frans van Houten Chief Executive Officer
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Feike Sijbesma Chairman-Supervisory Board
Jan Kimpen Chief Medical Officer
Sophie Bechu Chief Operating Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PHILIPS NV-11.48%28 130
THERMO FISHER SCIENTIFIC-17.01%221 810
DANAHER CORPORATION-17.94%190 628
INTUITIVE SURGICAL, INC.-26.87%94 475
SIEMENS HEALTHINEERS AG-12.06%73 622
EDWARDS LIFESCIENCES CORPORATION-21.30%67 821